Biotechnology Start-Up CapeBio Technologies Seeks To Create Innovations That Improve The Quality Of Life In Africa
Biotechnology Start-Up CapeBio Technologies Seeks To Create Innovations That Improve The Quality Of Life In Africa.
CapeBio Technologies is a South African biotechnology company that specialises in biomanufacturing of molecular biology enzyme technologies. These products are sourced from rich South African indigenous biodiversity hotspots.
The company uses its Proprietary Technology for large scale Biomanufacturing of its Enzymes And Assays. Its enzymes are key drivers and components for molecular diagnostic assays. The company has experience in developing molecular, biotechnology and bioinformatics technologies and their applications, it is also a 100% BBBEE company. Cape Bio Technologies’ vision is to create excellent innovations that improve the quality of life in Africa and beyond. It’s mission is to develop “best-in-class “life science research enzymes, assays and kits discovered from the rich African indigenous microbial diversity.
The company was founded by Daniel Ndima who is a scientist that specialises in structural biology of infectious diseases. He is a protein engineer, trained in protein crystallography, bioprocess engineering and biomanufacturing. He has a Bachelor & Honours degrees in Biotechnology and a Masters degree in structural biology. Throughout his academic journey, he was awarded multiple awards and scholarships for his excellence in academics, social responsibility, student leadership, and entrepreneurial initiatives. He is also the founder and former Executive Chairman of Achievers Elevation Foundation – A youth skills development NGO based in the Western Cape Province.
CapeBio’s success can primarily be attributed to the support and guidance it received at the Council of Scientific and Industrial Research (CSIR) when the company was still a research project. The project was further supported by the South African Government’s Department of Science and Innovation (DSI), which ultimately led to its firm establishment as a privately-owned company.
Today, CapeBio has comprehensive network of local and international stakeholders and partners, as well as research collaborators and clientele. This unique network ensures the conformity of all its products to internationally approved gold standards
